[Hearing recovery in sudden deafness with profound hearing loss] | Canada Hyperbarics Skip to main content
Study Nihon Jibiinkoka Gakkai Kaiho 1998

[Hearing recovery in sudden deafness with profound hearing loss]

Sano H, Okamoto M, Hirayama M, Ono Y, Nitta M — Nihon Jibiinkoka Gakkai Kaiho, 1998

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated hearing recovery in 51 patients with sudden, severe hearing loss to see how their hearing improved after different treatments, including some who received hyperbaric oxygen therapy.

What They Found

Most patients, 44 out of 51, achieved ultimate hearing levels between 55 and 80 dB, with only seven patients remaining worse than 100 dB. Two patients experienced a complete recovery, reaching hearing levels better than 20 dB. The study found no significant difference in hearing recovery between patients treated in an outpatient setting and those treated in the hospital, which included additional hyperbaric oxygen therapy or nerve blocks. Patients who started recovering within 14 days from onset generally achieved better ultimate hearing levels (better than 80 dB) compared to those who started recovering later.

What This Means for Canadian Patients

For Canadian patients experiencing sudden, profound hearing loss, these findings suggest that some level of hearing recovery is possible, with a small chance of complete recovery. While hyperbaric oxygen therapy was part of the hospital treatment group, this study did not clearly show it provided a distinct advantage over outpatient care for overall hearing improvement. However, the timing of treatment initiation appears important, as starting recovery earlier may lead to better long-term hearing outcomes.

Canadian Relevance

This study was not conducted by Canadian authors or in Canada. Sudden sensorineural hearing loss is not currently a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

This study had a relatively small sample size of 51 patients, and the effects of hyperbaric oxygen therapy were not isolated, as it was combined with other treatments or nerve blocks in the hospital group.

Was this summary helpful?

Study Details

Study Type Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 9711085
Year Published 1998
Journal Nihon Jibiinkoka Gakkai Kaiho
MeSH Terms Adolescent; Adult; Aged; Alprostadil; Anti-Inflammatory Agents; Child; Female; Hearing; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nerve Block; Prognosis; Stellate Ganglion; Steroids; Time Factors; Vasodilator Agents

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.